Athenex

United States
Spicer, Minnesota, United States
716-427-2950 ★

Company profile

Athenex company profile

Athenex focuses on the development and commercialization of therapies for cancer and immunomodulatory diseases. Its mission is to become a global leader in bringing innovative cancer treatments to the market and improve health outcomes. The company was founded in 2003 in Buffalo, New York, and has since grown to have operations across the U.S., China, Hong Kong, Taiwan, and the U.K.

Business identity

Contact email
[email protected]
Phone number
716-427-2950
Operating status
Closed
Company type
For Profit
Employee range
00251-00500 employees
Revenue range
$50K+
Founded
2003-01-01

Headquarters

Headquarters
Spicer, Minnesota, United States
Postal code
14203
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
10
Total equity funding
$342.1M
Last funding
Post Ipo Equity / $30M / 2022-08-11
Last equity funding
Post Ipo Equity / $30M
Investors
4
Lead investors
2
Founders
2
Articles
87
Closed on
2023-09-12
Exited on
2017-06-14

Founders and investors

Founders

Allen BarnettDavid Hangauer

Lead investors

Kingdon CapitalPerceptive Advisors

Investors

Kingdon CapitalMandra CapitalOrbiMedPerceptive Advisors

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.